Regulation of cancer metabolism by O-GlcNAcylation

Glycoconjugate Journal

Volumn 31, Issue 3, 2014, Pages 185-191

  Li, Zhonghua ^a   Yi, Wen ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Cancer metabolism; O GlcNAcylation; Oncogenic signaling; Posttranslational modification

Indexed keywords

6 PHOSPHOFRUCTOKINASE; BINDING PROTEIN; CARBOHYDRATE RESPONSIVE ELEMENT BINDING PROTEIN; CYTOCHROME C OXIDASE; FATTY ACID SYNTHASE; GLUCOSE TRANSPORTER; GLUTAMINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 3 RECEPTOR; LACTATE DEHYDROGENASE; MYC PROTEIN; N ACETYLGLUCOSAMINE; O LINKED BETA N ACETYLGLUCOSAMINE; PENTOSE PHOSPHATE; PROTEIN P53; PYRUVATE KINASE; SERINE; THREONINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; ENZYME; MLXIPL PROTEIN, HUMAN;

AMINOACYLATION; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL METABOLISM; CELL PROLIFERATION; ENZYME METABOLISM; ENZYME REGULATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; LIPOGENESIS; NEOPLASM; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; METABOLISM;

ACETYLGLUCOSAMINE; ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; ENZYMES; HUMANS; NEOPLASMS; NF-KAPPA B; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84897566671     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-013-9515-5     Document Type: Article

References (71)

1. Hanahan, D., Weinberg, R.A.: Hallmarks of cancer: the next generation. Cell 144 (5), 646-674 (2011)
2. Warburg, O.: On respiratory impairment in cancer cells. Science 124 (3215), 269-270 (1956)
3. Warburg, O.,Wind, F.,Negelein, E.: Themetabolismof tumors in the body. J. Gen. Physiol. 8 (6), 519-530 (1927)
4. Vander Heiden, M.G., Cantley, L.C., Thompson, C.B.: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 (5930), 1029-1033 (2009)
5. DeBerardinis, R.J., Lum, J.J., Hatzivassiliou, G., Thompson, C.B.: The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7 (1), 11-20 (2008)
6. Lum, J.J., Bui, T., Gruber, M., Gordan, J.D., DeBerardinis, R.J., Covello, K.L., Simon, M.C., Thompson, C.B.: The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev. 21 (9), 1037-1049 (2007)
7. Osthus, R.C., Shim, H., Kim, S., Li, Q., Reddy, R., Mukherjee, M., Xu, Y., Wonsey, D., Lee, L.A., Dang, C.V.: Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J. Biol. Chem. 275 (29), 21797-21800 (2000)
8. Ward, P.S., Thompson, C.B.: Signaling in control of cell growth and metabolism. Cold Spring Harb. Perspect. Biol. 4 (7), a006783 (2012)
9. David, C.J., Chen, M., Assanah,M., Canoll, P.,Manley, J.L.:HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463 (7279), 364-368 (2010)
10. Shim, H., Dolde, C., Lewis, B.C., Wu, C.S., Dang, G., Jungmann, R.A., Dalla-Favera, R., Dang, C.V.: c-Myc transactivation of LDHA: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. U. S. A. 94 (13), 6658-6663 (1997)
11. Gao, P., Tchernyshyov, I., Chang, T.C., Lee, Y.S., Kita, K., Ochi, T., Zeller, K.I., De Marzo, A.M., Van Eyk, J.E., Mendell, J.T., Dang, C.V.: c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458 (7239), 762-765 (2009)
12. Wise, D.R., DeBerardinis, R.J., Mancuso, A., Sayed, N., Zhang, X.Y., Pfeiffer, H.K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S.B., Thompson, C.B.: Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. U. S. A. 105 (48), 18782-18787 (2008)
13. Wellen, K.E., Thompson, C.B.: A two-way street: reciprocal regulation of metabolism and signalling. Nat. Rev. Mol. Cell Biol. 13 (4), 270-276 (2012)
14. Ruan, H.B., Singh, J.P., Li, M.D.,Wu, J., Yang, X.: Cracking the OGlcNAc code in metabolism. Trends Endocrinol.Metab. 24 (6), 301-309 (2013)
15. Ma, Z., Vosseller, K.: O-GlcNAc in cancer biology. Amino Acids 45 (4), 719-733 (2013)
16. Ngoh, G.A., Jones, S.P.: New insights into metabolic signaling and cell survival: the role of beta-O-linkage of N-acetylglucosamine. J. Pharmacol. Exp. Ther. 327 (3), 602-609 (2008)
17. Vocadlo, D.J.: O-GlcNAc processing enzymes: catalytic mechanisms, substrate specificity, and enzyme regulation. Curr. Opin. Chem. Biol. 16 (5-6), 488-497 (2012)
18. Marshall, S., Bacote, V., Traxinger, R.R.: Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem. 266 (8), 4706-4712 (1991)
19. Ma, J., Hart, G.W.: Protein O-GlcNAcylation in diabetes and diabetic complications. Expert Rev. Proteomics 10 (4), 365-380 (2013)
20. Wellen, K.E., Lu, C., Mancuso, A., Lemons, J.M., Ryczko, M., Dennis, J.W., Rabinowitz, J.D., Coller, H.A., Thompson, C.B.: The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev. 24 (24), 2784-2799 (2010)
21. Krzeslak, A., Forma, E., Bernaciak, M., Romanowicz, H., Brys, M.: Gene expression of O-GlcNAc cycling enzymes in human breast cancers. Clin. Exp. Med. 12 (1), 61-65 (2012)
22. Mi, W., Gu, Y., Han, C., Liu, H., Fan, Q., Zhang, X., Cong, Q., Yu, W.: O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. Biochim. Biophys. Acta 1812 (4), 514-519 (2011)
23. Zhu, Q., Zhou, L., Yang, Z., Lai, M., Xie, H., Wu, L., Xing, C., Zhang, F., Zheng, S.: O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation. Med. Oncol. 29 (2), 985-993 (2012)
24. Rozanski, W., Krzeslak, A., Forma, E., Brys, M., Blewniewski, M., Wozniak, P., Lipinski, M.: Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level. Clin Lab 58 (5-6), 579-583 (2012)
25. Krzeslak, A., Wojcik-Krowiranda, K., Forma, E., Bienkiewicz, A., Brys,M.: Expression of genes encoding for enzymes associated with O-GlcNAcylation in endometrial carcinomas: clinicopathologic correlations. Ginekol. Pol. 83 (1), 22-26 (2012)
26. Lynch, T.P., Ferrer, C.M., Jackson, S.R., Shahriari, K.S., Vosseller, K., Reginato, M.J.: Critical role of O-Linked beta-Nacetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J. Biol. Chem. 287 (14), 11070-11081 (2012)
27. Shi,Y., Tomic, J.,Wen, F., Shaha, S., Bahlo,A.,Harrison, R., Dennis, J.W., Williams, R., Gross, B.J., Walker, S., Zuccolo, J., Deans, J.P., Hart, G.W., Spaner, D.E.: Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia. Leukemia 24 (9), 1588-1598 (2010)
28. Ma, Z., Vocadlo, D.J., Vosseller, K.: Hyper-O-GlcNAcylation is antiapoptotic and maintains constitutive NF-kappaB activity in pancreatic cancer cells. J. Biol. Chem. 288 (21), 15121-15130 (2013)
29. Yi, W., Clark, P.M., Mason, D.E., Keenan, M.C., Hill, C., Goddard 3rd, W.A., Peters, E.C., Driggers, E.M., Hsieh-Wilson, L.C.: Phosphofructokinase 1 glycosylation regulates cell growth and metabolism. Science 337 (6097), 975-980 (2012)
30. Caldwell, S.A., Jackson, S.R., Shahriari, K.S., Lynch, T.P., Sethi, G., Walker, S., Vosseller, K., Reginato, M.J.: Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 29 (19), 2831-2842 (2010)
31. Yang, W.H., Kim, J.E., Nam, H.W., Ju, J.W., Kim, H.S., Kim, Y.S., Cho, J.W.: Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat. Cell Biol. 8 (10), 1074-1083 (2006)
32. Yang, X., Su, K., Roos, M.D., Chang, Q., Paterson, A.J., Kudlow, J.E.: O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc. Natl. Acad. Sci. U. S. A. 98 (12), 6611-6616 (2001)
33. Chou, T.Y., Hart, G.W., Dang, C.V.: c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J. Biol. Chem. 270 (32), 18961-18965 (1995)
34. Yang, W.H., Park, S.Y., Nam, H.W., do Kim, H., Kang, J.G., Kang, E.S., Kim, Y.S., Lee, H.C., Kim, K.S., Cho, J.W.: NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc. Natl. Acad. Sci. U. S. A. 105 (45), 17345-17350 (2008)
35. Moore, J.P., Hancock, D.C., Littlewood, T.D., Evan, G.I.: A sensitive and quantitative enzyme-linked immunosorbence assay for the c-myc and N-myc oncoproteins. Oncogene Res 2 (1), 65-80 (1987)
36. Gregory, M.A., Qi, Y., Hann, S.R.: Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J. Biol. Chem. 278 (51), 51606-51612 (2003)
37. Itkonen, H.M.,Minner, S., Guldvik, I.J., Sandmann,M.J., Tsourlakis, M.C., Berge, V., Svindland, A., Schlomm, T.,Mills, I.G.: O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. Cancer Res. 73 (16), 5277-5287 (2013)
38. Kruse, J.P., Gu, W.: Modes of p53 regulation. Cell 137 (4), 609-622 (2009)
39. Dai, C., Gu, W.: p53 post-translational modification: deregulated in tumorigenesis. Trends Mol. Med. 16 (11), 528-536 (2010)
40. Ide, T., Brown-Endres, L., Chu, K., Ongusaha, P.P., Ohtsuka, T., El- Deiry, W.S., Aaronson, S.A., Lee, S.W.: GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress. Mol. Cell 36 (3), 379-392 (2009)
41. Bensaad, K., Tsuruta, A., Selak, M.A., Vidal, M.N., Nakano, K., Bartrons, R., Gottlieb, E., Vousden, K.H.: TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126 (1), 107-120 (2006)
42. Kondoh, H., Lleonart, M.E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., Beach, D.: Glycolytic enzymes can modulate cellular life span. Cancer Res. 65 (1), 177-185 (2005)
43. Matoba, S., Kang, J.G., Patino, W.D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P.J., Bunz, F., Hwang, P.M.: p53 regulates mitochondrial respiration. Science 312 (5780), 1650-1653 (2006)
44. Brosh, R., Rotter, V.:When mutants gain new powers: news from the mutant p53 field. Nat. Rev. Cancer 9 (10), 701-713 (2009)
45. Oren, M., Rotter, V.: Mutant p53 gain-of-function in cancer. Cold Spring Harb. Perspect. Biol. 2 (2), a001107 (2010)
46. Rivlin, N., Brosh, R., Oren, M., Rotter, V.: Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis. Genes Cancer 2 (4), 466-474 (2011)
47. Bensaad, K., Vousden, K.H.: p53: new roles in metabolism. Trends Cell Biol. 17 (6), 286-291 (2007)
48. Karin, M.: Nuclear factor-kappaB in cancer development and progression. Nature 441 (7092), 431-436 (2006)
49. Perkins, N.D.: The diverse and complex roles of NF-kappaB subunits in cancer. Nat. Rev. Cancer 12 (2), 121-132 (2012)
50. Kawauchi, K., Araki, K., Tobiume, K., Tanaka, N.: p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nat. Cell Biol. 10 (5), 611- 618 (2008)
51. Johnson, R.F., Witzel, I.I., Perkins, N.D.: p53-dependent regulation of mitochondrial energy production by the RelA subunit of NFkappaB. Cancer Res. 71 (16), 5588-5597 (2011)
52. Kawauchi, K., Araki, K., Tobiume, K., Tanaka, N.: Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-Nacetyl glucosamine modification. Proc. Natl. Acad. Sci. U. S. A. 106 (9), 3431-3436 (2009)
53. Tong, X., Zhao, F., Mancuso, A., Gruber, J.J., Thompson, C.B.: The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 106 (51), 21660-21665 (2009)
54. Ma, L., Robinson, L.N., Towle, H.C.: ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver. J. Biol. Chem. 281 (39), 28721-28730 (2006)
55. Sakiyama, H., Fujiwara, N., Noguchi, T., Eguchi, H., Yoshihara, D., Uyeda, K., Suzuki, K.: The role of O-linked GlcNAc modification on the glucose response of ChREBP. Biochem. Biophys. Res. Commun. 402 (4), 784-789 (2010)
56. Guinez, C., Filhoulaud, G., Rayah-Benhamed, F., Marmier, S., Dubuquoy, C., Dentin, R., Moldes, M., Burnol, A.F., Yang, X., Lefebvre, T., Girard, J., Postic, C.: O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 60 (5), 1399-1413 (2011)
57. Clark, P.M., Dweck, J.F., Mason, D.E., Hart, C.R., Buck, S.B., Peters, E.C., Agnew, B.J., Hsieh-Wilson, L.C.: Direct in-gel fluorescence detection and cellular imaging of O-GlcNAc-modified proteins. J. Am. Chem. Soc. 130 (35), 11576-11577 (2008)
58. Moens, U., Kostenko, S.: Structure and function of MK5/PRAK: the loner among the mitogen-activated protein kinase-activated protein kinases. Biol. Chem. 394 (9), 1115-1132 (2013)
59. Sebolt-Leopold, J.S.: Advances in the development of cancer therapeutics directed against the RAS-mitogen-activated protein kinase pathway. Clin. Cancer Res. 14 (12), 3651-3656 (2008)
60. Kneass, Z.T., Marchase, R.B.: Protein O-GlcNAc modulates motility-associated signaling intermediates in neutrophils. J. Biol. Chem. 280 (15), 14579-14585 (2005)
61. Olivier-Van Stichelen, S., Drougat, L., Dehennaut, V., El Yazidi-Belkoura, I., Guinez, C., Mir, A.M., Michalski, J.C., Vercoutter-Edouart, A.S., Lefebvre, T.: Serum-stimulated cell cycle entry promotes ncOGT synthesis required for cyclin D expression. Oncogenesis 1, e36 (2012)
62. Dehennaut, V., Slomianny, M.C., Page, A., Vercoutter-Edouart, A.S., Jessus, C., Michalski, J.C., Vilain, J.P., Bodart, J.F., Lefebvre, T.: Identification of structural and functional O-linked N-acetylglucosamine-bearing proteins in Xenopus laevis oocyte. Mol. Cell. Proteomics 7 (11), 2229-2245 (2008)
63. Neckers, L.: Using natural product inhibitors to validate Hsp90 as a molecular target in cancer. Curr. Top.Med. Chem. 6 (11), 1163-1171 (2006)
64. Fardini, Y., Dehennaut, V., Lefebvre, T., Issad, T.: O-GlcNAcylation: a new cancer hallmark? Front. Endocrinol. (Lausanne) 4, 99 (2013)
65. Nandi, A., Sprung, R., Barma, D.K., Zhao, Y., Kim, S.C., Falck, J.R.: Global identification of O-GlcNAc-modified proteins. Anal. Chem. 78 (2), 452-458 (2006)
66. Perez-Cervera, Y., Dehennaut, V., Aquino Gil, M., Guedri, K., Solorzano Mata, C.J., Olivier-Van Stichelen, S., Michalski, J.C., Foulquier, F., Lefebvre, T.: Insulin signaling controls the expression of O-GlcNAc transferase and its interaction with lipid microdomains. FASEB J. 27 (9), 3478-3486 (2013)
67. Kanwal, S., Fardini, Y., Pagesy, P., N'Tumba-Byn, T., Pierre-Eugene, C., Masson, E., Hampe, C., Issad, T.: O-GlcNAcylation-inducing treatments inhibit estrogen receptor alpha expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells. PLoS One 8 (7), e69150 (2013)
68. Fay, J.R., Steele, V., Crowell, J.A.: Energy homeostasis and cancer prevention: the AMP-activated protein kinase. Cancer Prev. Res. (Phila) 2 (4), 301-309 (2009)
69. Faubert, B., Boily, G., Izreig, S., Griss, T., Samborska, B., Dong, Z., Dupuy, F., Chambers, C., Fuerth, B.J., Viollet, B., Mamer, O.A., Avizonis, D., DeBerardinis, R.J., Siegel, P.M., Jones, R.G.: AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab. 17 (1), 113-124 (2013)
70. Luo, B., Parker, G.J., Cooksey, R.C., Soesanto, Y., Evans,M., Jones, D., McClain, D.A.: Chronic hexosamine flux stimulates fatty acid oxidation by activating AMP-activated protein kinase in adipocytes. J. Biol. Chem. 282 (10), 7172-7180 (2007)
71. Cheung, W.D., Hart, G.W.: AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation. J. Biol. Chem. 283 (19), 13009-13020 (2008)